Purple Biotech Ltd.PPBTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+259.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+259.1%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
46.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 100.00% |
| Q2 2025 | 21.84% |
| Q1 2025 | 1.79% |
| Q4 2024 | 38.88% |
| Q3 2024 | 17.13% |
| Q2 2024 | 21.76% |
| Q1 2024 | -2.01% |
| Q4 2023 | -36.31% |
| Q3 2023 | 30.03% |
| Q2 2023 | 13.89% |
| Q1 2023 | -43.97% |
| Q4 2022 | -16.22% |
| Q3 2022 | 2.16% |
| Q2 2022 | 31.59% |
| Q1 2022 | -44.34% |
| Q4 2021 | -27.39% |
| Q3 2021 | 42.93% |
| Q2 2021 | -47.28% |
| Q1 2021 | -92051.97% |
| Q4 2020 | -2.09% |
| Q3 2020 | -60.55% |
| Q2 2020 | 0.00% |
| Q1 2020 | -40.04% |
| Q4 2019 | 0.00% |
| Q3 2019 | -45.48% |
| Q2 2019 | 0.00% |
| Q1 2019 | 54.52% |
| Q4 2018 | 0.00% |
| Q3 2018 | -43.65% |
| Q2 2018 | 0.00% |
| Q1 2018 | 11.63% |
| Q4 2017 | 0.00% |
| Q3 2017 | 15.94% |
| Q2 2017 | 0.00% |
| Q1 2017 | -22.21% |
| Q4 2016 | 0.00% |
| Q3 2016 | -58.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 99.87% |
| Q4 2015 | 13.34% |